DataMeds AI, Inc.

• Deferred Tax Assets, Valuation Allowance·As of Dec 31, 2024

  Major restatement

  $4M▲ 60.5%

  was$2.5M

  Revised up in a 10-K.

  No amendment filed

  As reported · Mar 25, 202510-K · Mar 20, 2026us-gaap:DeferredTaxAssetsValuationAllowanceReport

  Evidence

• Deferred Tax Assets, Operating Loss Carryforwards·As of Dec 31, 2024

  Notable restatement

  $2.6M▲ 4.8%

  was$2.5M

  Revised up in a 10-K.

  No amendment filed

  As reported · Mar 25, 202510-K · Mar 20, 2026us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsReport

  Evidence

• Other Assets, Noncurrent·As of Dec 31, 2024

  Minor restatement

  $1.4M▲ 1.2%

  was$1.4M

  Revised up in a 10-K.

  No amendment filed

  As reported · Mar 25, 202510-K · Mar 20, 2026us-gaap:OtherAssetsNoncurrentReport

  Evidence

Restatements are detected by comparing every vintage of a fact across all of DataMeds AI, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows MEDS's most significant revisions, and a figure absent from it has not been certified as unrevised.